Cancer patients shouldn’t be responsible for out-of-pocket costs
The costs of cancer are literally killing patients. But there is a clear solution. Patients diagnosed with cancer should not be responsible for any deductibles, copays, or other cost-sharing.
Should FDA Grant Accelerated Approval to Duchenne Muscular Dystrophy Gene Therapy?
— Waiting for the results of the SRP-9001 confirmatory trial may be a better move. by Reshma Ramachandran, MD, MPP, MHS, and Holly Fernandez Lynch, JD, MBe
Are We Ready to Care for Our Aging Population?
There’s a seismic shift of Americans going into retirement by 2030. They’ll need more medical care as they age — and the resources to pay for it.
CHIBE and the Department of Medical Ethics & Health Policy Volunteer at Cradles to Crayons
Members of Penn’s Department of Medical Ethics and Health Policy and the Center for Health Incentives and Behavioral Economics (CHIBE) volunteered at Cradles to Crayons this May by cleaning and sorting books and sorting clothing.
Do Accelerated Approvals Really Benefit Patients? With Ravi Parikh, MD, MPP
In this interview with OncData, he further discusses his research and gives a thought-provoking analysis of what these findings could mean for the future of the accelerated approval program, as well as how the multidisciplinary team could better advocate and let their voices be heard for more quality clinical trials.